Roles of Trained Immunity in the Pathogenesis of Cholangiopathies: A Therapeutic Target

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216 · see citing works

Trained immunity: A program of innate immune memory in health and– disease

Netea, M. G., Joosten, L. A. B., Latz, E., Mills, K. H. G., Natoli, G., Stunnenberg, H. G., O’Neill, L. A. J., & Xavier, R. J. (2016) · Science · doi:10.1126/science.aaf1098 · Cited by 2,768 · see citing works

Defining trained immunity and its role in health and disease

Netea, M. G., Domínguez-Andrés, J., Barreiro, L. B., Chavakis, T., Divangahi, M., Fuchs, E., Joosten, L. A. B., van der Meer, J. W. M., Mhlanga, M. M., Mulder, W. J. M., et al. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0285-6 · Cited by 2,690 · see citing works

mTOR- and HIF-1α–mediated aerobic glycolysis as metabolic basis for trained immunity

Cheng, S.-C., Quintin, J., Cramer, R. A., Shepardson, K. M., Saeed, S., Kumar, V., Giamarellos-Bourboulis, E. J., Martens, J. H. A., Rao, N. A., Aghajanirefah, A., et al. (2014) · Science · doi:10.1126/science.1250684 · Cited by 2,224 · see citing works

Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases

Aggarwal, B. B., & Harikumar, K. B. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.06.010 · Cited by 2,043 · see citing works

Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity

Saeed, S., Quintin, J., Kerstens, H. H. D., Rao, N. A., Aghajanirefah, A., Matarese, F., Cheng, S.-C., Ratter, J., Berentsen, K., van der Ent, M. A., et al. (2014) · Science · doi:10.1126/science.1251086 · Cited by 1,761 · see citing works

Bacille Calmette-Guérin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes

Kleinnijenhuis, J., Quintin, J., Preijers, F., Joosten, L. A. B., Ifrim, D. C., Saeed, S., Jacobs, C., van Loenhout, J., de Jong, D., Stunnenberg, H. G., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202870109 · Cited by 1,728 · see citing works

Trained Immunity: A Memory for Innate Host Defense

Netea, M. G., Quintin, J., & van der Meer, J. W. M. (2011) · Cell Host & Microbe · doi:10.1016/j.chom.2011.04.006 · Cited by 1,697 · see citing works

Molecular mechanisms regulating NLRP3 inflammasome activation

Jo, E.-K., Kim, J. K., Shin, D.-M., & Sasakawa, C. (2016) · Cellular & Molecular Immunology · doi:10.1038/cmi.2015.95 · Cited by 1,378 · see citing works

Gene-specific control of inflammation by TLR-induced chromatin modifications

Foster, S. L., Hargreaves, D. C., & Medzhitov, R. (2007) · Nature · doi:10.1038/nature05836 · Cited by 1,344 · see citing works

Cholangiocarcinoma

DeOliveira, M. L., Cunningham, S. C., Cameron, J. L., Kamangar, F., Winter, J. M., Lillemoe, K. D., Choti, M. A., Yeo, C. J., & Schulick, R. D. (2007) · Annals of Surgery · doi:10.1097/01.sla.0000251366.62632.d3 · Cited by 1,301 · see citing works

Candida albicans Infection Affords Protection against Reinfection via Functional Reprogramming of Monocytes

Quintin, J., Saeed, S., Martens, J. H. A., Giamarellos-Bourboulis, E. J., Ifrim, D. C., Logie, C., Jacobs, L., Jansen, T., Kullberg, B.-J., Wijmenga, C., et al. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.06.006 · Cited by 1,289 · see citing works

Toll-like receptor–induced changes in glycolytic metabolism regulate dendritic cell activation

Krawczyk, C. M., Holowka, T., Sun, J., Blagih, J., Amiel, E., DeBerardinis, R. J., Cross, J. R., Jung, E., Thompson, C. B., Jones, R. G., et al. (2010) · Blood · doi:10.1182/blood-2009-10-249540 · Cited by 1,246 · see citing works

Primary Biliary Cirrhosis

Schwab, M. (2011) · Springer eBooks · doi:10.1007/978-3-642-16483-5_4730 · Cited by 1,241 · see citing works

Diagnosis and Management of Primary Sclerosing Cholangitis

Chapman, R. W., Fevery, J., Kalloo, A. N., Nagorney, D. M., Boberg, K. M., Shneider, B. L., & Gores, G. J. (2009) · Hepatology · doi:10.1002/hep.23294 · Cited by 1,217 · see citing works

BCG Vaccination Protects against Experimental Viral Infection in Humans through the Induction of Cytokines Associated with Trained Immunity

Arts, R. J. W., Moorlag, S. J. C. F. M., Novakovic, B., Li, Y., Wang, S.-Y., Oosting, M., Kumar, V., Xavier, R. J., Wijmenga, C., Joosten, L. A. B., et al. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2017.12.010 · Cited by 1,190 · see citing works

Akt Signaling Pathway in Macrophage Activation and M1/M2 Polarization

Vergadi, E., Ieronymaki, E., Lyroni, K., Vaporidi, K., & Tsatsanis, C. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601515 · Cited by 1,148 · see citing works

Primary biliary cirrhosis # †

Lindor, K. D., Gershwin, E. M., Poupon, R., Kaplan, M., Bergasa, N. V., & Heathcote, J. E. (2009) · Hepatology · doi:10.1002/hep.22906 · Cited by 1,099 · see citing works

Signaling cross-talk between TGF-β/BMP and other pathways

Guo, X., & Wang, X. (2008) · Cell Research · doi:10.1038/cr.2008.302 · Cited by 1,027 · see citing works

The Warburg Effect Dictates the Mechanism of Butyrate-Mediated Histone Acetylation and Cell Proliferation

Donohoe, D. R., Collins, L. B., Wali, A., Bigler, R., Sun, W., & Bultman, S. J. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.08.033 · Cited by 993 · see citing works

RAS/ERK Signaling Promotes Site-specific Ribosomal Protein S6 Phosphorylation via RSK and Stimulates Cap-dependent Translation

Roux, P. P., Shahbazian, D., Vu, H., Holz, M. K., Cohen, M. S., Taunton, J., Sonenberg, N., & Blenis, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700906200 · Cited by 749 · see citing works

Critical role for the chemokine receptor CXCR6 in NK cell–mediated antigen-specific memory of haptens and viruses

Paust, S., Gill, H. S., Wang, B., Flynn, M. P., Moseman, E. A., Senman, B. C., Szczepanik, M., Telenti, A., Askenase, P. W., Compans, R. W., et al. (2010) · Nature Immunology · doi:10.1038/ni.1953 · Cited by 695 · see citing works

β-Glucan Reverses the Epigenetic State of LPS-Induced Immunological Tolerance

Novakovic, B., Habibi, E., Wang, S.-Y., Arts, R. J. W., Davar, R., Megchelenbrink, W., Kim, B., Kuznetsova, T., Kox, M., Zwaag, J., et al. (2016) · Cell · doi:10.1016/j.cell.2016.09.034 · Cited by 689 · see citing works

Primary Biliary Cirrhosis Associated with <i>HLA, IL12A,</i> and <i>IL12RB2</i> Variants

Hirschfield, G. M., Liu, X., Xu, C., Lu, Y., Xie, G., Lu, Y., Gu, X., Walker, E. J., Jing, K., Juran, B. D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810440 · Cited by 594 · see citing works

Expanding mTOR signaling

Yang, Q., & Guan, K. (2007) · Cell Research · doi:10.1038/cr.2007.64 · Cited by 540 · see citing works

Therapeutic targeting of trained immunity

Mulder, W. J. M., Ochando, J., Joosten, L. A. B., Fayad, Z. A., & Netea, M. G. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0025-4 · Cited by 446 · see citing works

Pathogenesis of Primary Sclerosing Cholangitis and Advances in Diagnosis and Management

Eaton, J. E., Talwalkar, J. A., Lazaridis, K. N., Gores, G. J., & Lindor, K. D. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.06.052 · Cited by 436 · see citing works

Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD

Sabino, J., Vieira-Silva, S., Machiels, K., Joossens, M., Falony, G., Ballet, V., Ferrante, M., Van Assche, G., Van der Merwe, S., Vermeire, S., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-311004 · Cited by 413 · see citing works

Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis

Bajer, L., Kverka, M., Kostovčík, M., Mačinga, P., Dvořák, J., Stehlíková, Z., Březina, J., Wohl, P., Špičák, J., & Drastich, P. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i25.4548 · Cited by 360 · see citing works

The Role of Monocytes and Macrophages in Autoimmune Diseases: A Comprehensive Review

Ma, W., Gao, F., Gu, K., & Chen, D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01140 · Cited by 360 · see citing works

Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats

Keshavarzian, A., Farhadi, A., Forsyth, C. B., Rangan, J., Jakate, S. M., Shaikh, M. W., Banan, A., & Fields, J. Z. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.10.028 · Cited by 359 · see citing works

Interleukin‐1 and inflammasomes in alcoholic liver disease/acute alcoholic hepatitis and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

Tilg, H., Moschen, A. R., & Szabó, G. (2016) · Hepatology · doi:10.1002/hep.28456 · Cited by 319 · see citing works

Universal screening for biliary atresia using an infant stool color card in Taiwan†

Hsiao, C., Chang, M., Chen, H., Lee, H., Wu, T., Lin, C., Yang, Y., Chen, A., Tiao, M., Lau, B.-H., et al. (2008) · Hepatology · doi:10.1002/hep.22182 · Cited by 315 · see citing works

Pathogenesis of cholestatic liver disease and therapeutic approaches

Hirschfield, G. M., Heathcote, E. J., & Gershwin, M. E. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.09.004 · Cited by 287 · see citing works

Epigenetics and Trained Immunity

van der Heijden, C. D. C. C., Noz, M. P., Joosten, L. A. B., Netea, M. G., Riksen, N. P., & Keating, S. T. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7310 · Cited by 284 · see citing works

Fecal microbiota transplantation in patients with primary sclerosing cholangitis: a pilot clinical trial

Allegretti, J. R., Kassam, Z., Carrellas, M., Mullish, B. H., Marchesi, J. R., Pechlivanis, A., Smith, M., Gerardin, Y., Timberlake, S., Pratt, D. S., et al. (2019) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000115 · Cited by 234 · see citing works

Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis

Tabibian, J. H., O'Hara, S. P., Trussoni, C. E., Tietz, P. S., Splinter, P. L., Mounajjed, T., Hagey, L. R., & LaRusso, N. F. (2016) · Hepatology · doi:10.1002/hep.27927 · Cited by 223 · see citing works

The Cholangiopathies

Lazaridis, K. N., & LaRusso, N. F. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2015.03.017 · Cited by 216 · see citing works

Transient Activation of Autophagy via Sox2-Mediated Suppression of mTOR Is an Important Early Step in Reprogramming to Pluripotency

Wang, S., Xia, P., Ye, B., Huang, G., Liu, J., & Fan, Z. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.10.005 · Cited by 209 · see citing works

Altered Monocyte Responses to Defined TLR Ligands in Patients With Primary Biliary Cirrhosis *

Mao, T. K., Lian, Z.-X., Selmi, C., Ichiki, Y., Ashwood, P., Ansari, A. A., Coppel, R. L., Shimoda, S., Ishibashi, H., & Gershwin, E. M. (2005) · Hepatology · doi:10.1002/hep.20859 · Cited by 185 · see citing works

Macrophages contribute to the pathogenesis of sclerosing cholangitis in mice

Guicciardi, M. E., Trussoni, C. E., Krishnan, A., Bronk, S. F., Lorenzo Pisarello, M. J., O'Hara, S. P., Splinter, P. L., Gao, Y., Vig, P., Revzin, A., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.05.018 · Cited by 183 · see citing works

Long-term Outcomes of Fecal Microbiota Transplantation in Patients With Cirrhosis

Bajaj, J. S., Fagan, A., Gavis, E. A., Kassam, Z., Sikaroodi, M., & Gillevet, P. M. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.01.033 · Cited by 183 · see citing works

Clinical management of polycystic liver disease

van Aerts, R. M. M., van de Laarschot, L. F. M., Bañales, J. M., & Drenth, J. P. H. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.11.024 · Cited by 179 · see citing works

Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts†

Isse, K., Harada, K., Zen, Y., Kamihira, T., Shimoda, S., Harada, M., & Nakanuma, Y. (2005) · Hepatology · doi:10.1002/hep.20582 · Cited by 158 · see citing works

Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases

Fabris, L., Cadamuro, M., Fiorotto, R., Roskams, T., Spirlı̀, C., Melero, S., Sonzogni, A., Joplin, R., Okolicsànyi, L., & Strazzabosco, M. (2006) · Hepatology · doi:10.1002/hep.21143 · Cited by 147 · see citing works

Genome-wide association study identifies a susceptibility locus for biliary atresia on 10q24.2

García-Barceló, M.-M., Yeung, M.-Y., Miao, X., Tang, C. S.-M., Guo, C., So, M., Ngan, E., Lui, V. C. H., Chen, Y., Liu, X., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq196 · Cited by 144 · see citing works

Immunoglobulin M levels inversely correlate with CD40 ligand promoter methylation in patients with primary biliary cirrhosis

Lleo, A., Liao, J., Invernizzi, P., Zhao, M., Bernuzzi, F., Ma, L., Lanzi, G., Ansari, A. A., Coppel, R. L., Zhang, P., et al. (2012) · Hepatology · doi:10.1002/hep.24630 · Cited by 133 · see citing works

Molecular mechanisms of liver regeneration and protection for treatment of liver dysfunction and diseases

Fujiyoshi, M., & Ozaki, M. (2010) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1007/s00534-010-0304-2 · Cited by 124 · see citing works

The role of the interleukin‐1 family in trained immunity

Moorlag, S. J. C. F. M., Röring, R. J., Joosten, L. A. B., & Netea, M. G. (2017) · Immunological Reviews · doi:10.1111/imr.12617 · Cited by 124 · see citing works

Mechanisms of hepatocyte growth factor–mediated and epidermal growth factor–mediated signaling in transdifferentiation of rat hepatocytes to biliary epithelium

Limaye, P. B., Bowen, W. C., Orr, A. V., Luo, J., Tseng, G. C., & Michalopoulos, G. K. (2008) · Hepatology · doi:10.1002/hep.22221 · Cited by 120 · see citing works

Neonatal NK cells target the mouse duct epithelium via Nkg2d and drive tissue-specific injury in experimental biliary atresia

Shivakumar, P., Sabla, G. E., Whitington, P. F., Chougnet, C. A., & Bezerra, J. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38879 · Cited by 109 · see citing works

Macrophage recruitment by fibrocystin‐defective biliary epithelial cells promotes portal fibrosis in congenital hepatic fibrosis

Locatelli, L., Cadamuro, M., Spirlı̀, C., Fiorotto, R., Lecchi, S., Morell, C. M., Popov, Y. V., Scirpo, R., Matteis, M. D., Amenduni, M., et al. (2015) · Hepatology · doi:10.1002/hep.28382 · Cited by 108 · see citing works

Armed CD4+ Th1 effector cells and activated macrophages participate in bile duct injury in murine biliary atresia

Mack, C. L., Tucker, R. M., Sokol, R. J., & Kotzin, B. L. (2005) · Clinical Immunology · doi:10.1016/j.clim.2005.01.012 · Cited by 102 · see citing works

Interferon γ accelerates NF-κB activation of biliary epithelial cells induced by Toll-like receptor and ligand interaction

Harada, K., Isse, K., & Nakanuma, Y. (2006) · Journal of Clinical Pathology · doi:10.1136/jcp.2004.023507 · Cited by 98 · see citing works

Mammalian Target of Rapamycin Regulates Vascular Endothelial Growth Factor–Dependent Liver Cyst Growth in Polycystin-2–Defective Mice

Spirlı̀, C., Okolicsanyi, S., Fiorotto, R., Fabris, L., Cadamuro, M., Lecchi, S., Tian, X., Somlo, S., & Strazzabosco, M. (2009) · Hepatology · doi:10.1002/hep.23511 · Cited by 96 · see citing works

Curcumin improves sclerosing cholangitis in Mdr2 −/− mice by inhibition of cholangiocyte inflammatory response and portal myofibroblast proliferation

Baghdasaryan, A., Claudel, T., Kosters, A., Gumhold, J., Silbert, D., Thüringer, A., Leski, K., Fickert, P., KARPEN, S., & Trauner, M. A. (2010) · Gut · doi:10.1136/gut.2009.186528 · Cited by 95 · see citing works

Polycystic liver diseases: advanced insights into the molecular mechanisms

Perugorria, M. J., Masyuk, T. V., Marı́n, J. J. G., Marzioni, M., Bujanda, L., LaRusso, N. F., & Bañales, J. M. (2014) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2014.155 · Cited by 94 · see citing works

Primary sclerosing cholangitis and the microbiota: current knowledge and perspectives on etiopathogenesis and emerging therapies

Tabibian, J. H., O’Hara, S. P., & Lindor, K. D. (2014) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2014.913189 · Cited by 93 · see citing works

Cholangiociliopathies: genetics, molecular mechanisms and potential therapies

Masyuk, T. V., Masyuk, A. I., & LaRusso, N. F. (2009) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e328328f4ff · Cited by 89 · see citing works

Morphological and Functional Features of Hepatic Cyst Epithelium in Autosomal Dominant Polycystic Kidney Disease

Alvaro, D., Onori, P., Alpini, G. D., Franchitto, A., Jefferson, D. M., Torrice, A., Cardinale, V., Stefanelli, F., Mancino, M. G., Strazzabosco, M., et al. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070293 · Cited by 84 · see citing works

The Role of Stroma in Cholangiocarcinoma: The Intriguing Interplay between Fibroblastic Component, Immune Cell Subsets and Tumor Epithelium

Gentilini, A., Pastore, M., Marra, F., & Raggi, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102885 · Cited by 83 · see citing works

Natural killer cells regulate T cell immune responses in primary biliary cirrhosis

Shimoda, S., Hisamoto, S., Harada, K., Iwasaka, S., Chong, Y., Nakamura, M., Bekki, Y., Yoshizumi, T., Shirabe, K., Ikegami, T., et al. (2015) · Hepatology · doi:10.1002/hep.28122 · Cited by 82 · see citing works

Animal models of cholangiocarcinoma

Loeuillard, E. J., Fischbach, S. R., Gores, G. J., & Ilyas, S. I. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.03.026 · Cited by 82 · see citing works

Involvement of PI3K and ERK1/2 pathways in hepatocyte growth factor-induced cholangiocarcinoma cell invasion

Menakongka, A. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i6.713 · Cited by 69 · see citing works

In Vivo Study of Natural Killer (NK) Cell Cytotoxicity Against Cholangiocarcinoma in a Nude Mouse Model

JUNG, I. H., Kim, D. H., Yoo, D. K., BAEK, S. Y., Jeong, S. H., Jung, D., Park, S. W., & Chung, Y.-Y. (2018) · In Vivo · doi:10.21873/invivo.11307 · Cited by 69 · see citing works

DNA Hypomethylation Causes Bile Duct Defects in Zebrafish and Is a Distinguishing Feature of Infantile Biliary Atresia §Δ

Matthews, R. P., EauClaire, S. F., Mugnier, M. R., Lorent, K., Cui, S., Ross, M. M., Zhang, Z., Russo, P., & Pack, M. A. (2010) · Hepatology · doi:10.1002/hep.24106 · Cited by 68 · see citing works

Rapamycin Ameliorates Inflammation and Fibrosis in the Early Phase of Cirrhotic Portal Hypertension in Rats through Inhibition of mTORC1 but Not mTORC2

Wang, W., Yan, J., Wang, H., Shi, M., Zhang, M., Yang, W., Peng, C., & Li, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0083908 · Cited by 59 · see citing works

Tumor necrosis and infiltrating macrophages predict survival after curative resection for cholangiocarcinoma

Atanasov, G., Dietel, C., Feldbrügge, L., Benzing, C., Krenzien, F., Brandl, A., Mann, E., Englisch, J. P., Schierle, K., Robson, S. C., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1331806 · Cited by 59 · see citing works

Primary biliary cholangitis: A tale of epigenetically-induced secretory failure?

Rodrigues, P. M., Perugorria, M. J., Santos‐Laso, Á., Bujanda, L., Beuers, U. H., & Bañales, J. M. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.08.020 · Cited by 58 · see citing works

Recent progress in the etiopathogenesis of pediatric biliary disease, particularly Caroli's disease with congenital hepatic fibrosis and biliary atresia.

Nakanuma, Y., Harada, K., Sato, Y., & Ikeda, H. (2010) · PubMed · doi:10.14670/hh-25.223 · Cited by 48 · see citing works

Metformin attenuates myocardial remodeling and neutrophil recruitment after myocardial infarction in rat

Soraya, H., Rameshrad, M., Mokarizadeh, A., & Garjani, A. (2015) · Bioimpacts · doi:10.15171/bi.2015.02 · Cited by 45 · see citing works

Gal-3 Deficiency Suppresses Novosphyngobium aromaticivorans Inflammasome Activation and IL-17 Driven Autoimmune Cholangitis in Mice

Arsenijević, A., Milovanović, J., Stojanović, B., Djordjevic, D., Stanojević, I., Janković, N., Vojvodić, D., Arsenijević, N., Lukić, M. L., & Milovanović, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01309 · Cited by 44 · see citing works

The role of PTEN in regulation of hepatic macrophages activation and function in progression and reversal of liver fibrosis

Cheng, Y., Tian, Y., Xia, J., Wu, X., Yang, Y., Li, X., Huang, C., Meng, X., Ma, T., & Li, J. (2017) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2017.01.005 · Cited by 43 · see citing works

Array comparative genomic hybridization identifies novel potential therapeutic targets in cholangiocarcinoma

McKay, S. C., Unger, K., Pericleous, S., Stamp, G. W. H., Thomas, G. A., Hutchins, R., & Spalding, D. R. C. (2011) · HPB · doi:10.1111/j.1477-2574.2010.00286.x · Cited by 40 · see citing works

Regulation of epithelial injury and bile duct obstruction by NLRP3, IL-1R1 in experimental biliary atresia

Yang, L., Mizuochi, T., Shivakumar, P., Mourya, R., Luo, Z., Gutta, S., & Bezerra, J. A. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.05.038 · Cited by 38 · see citing works

Epigenetics in the primary biliary cholangitis and primary sclerosing cholangitis

Cheung, A., LaRusso, N., Gores, G., & Lazaridis, K. (2017) · Seminars in Liver Disease · doi:10.1055/s-0037-1603324 · Cited by 37 · see citing works

Cholangiopathy with Respect to Biliary Innate Immunity

Harada, K., & Nakanuma, Y. (2011) · International Journal of Hepatology · doi:10.1155/2012/793569 · Cited by 34 · see citing works

Clonorchis sinensis excretory/secretory products promote the secretion of TNF-alpha in the mouse intrahepatic biliary epithelial cells via Toll-like receptor 4

Yan, C., Wang, Y., Yu, Q., Cheng, X.-D., Zhang, B., Li, B., Zhang, B., Tang, R., & Zheng, K. (2015) · Parasites & Vectors · doi:10.1186/s13071-015-1171-0 · Cited by 34 · see citing works

Review of the Emerging Treatment of Clostridium difficile Infection with Fecal Microbiota Transplantation and Insights into Future Challenges

Kassam, Z., Lee, C., & Hunt, R. H. (2014) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2014.08.007 · Cited by 32 · see citing works

Activation of the PI3K/mTOR Pathway Is Involved in Cystic Proliferation of Cholangiocytes of the PCK Rat

Ren, X. S., Sato, Y., Harada, K., Sasaki, M., Furubo, S., Song, J. Y., & Nakanuma, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087660 · Cited by 31 · see citing works

Liver transplantation for cholangiocarcinoma

DeOliveira, M. L. (2014) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000087 · Cited by 31 · see citing works

Advances in liver surgery for cholangiocarcinoma

DeOliveira, M. L., Kambakamba, P., & Clavien, P. (2013) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3283600a92 · Cited by 16 · see citing works

Anti-bacterial and Anti-biofilm Evaluation of Thiazolopyrimidinone Derivatives Targeting the Histidine Kinase YycG Protein of Staphylococcus epidermidis

Lv, Z., Zhao, D., Chang, J., Liu, H., Wang, X., Zheng, J., Huang, R., Lin, Z., Shang, Y., Ye, L., et al. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00549 · Cited by 16 · see citing works

Polycystic liver disease: The interplay of genes causative for hepatic and renal cystogenesis

Masyuk, T. V., Masyuk, A. I., & LaRusso, N. F. (2017) · Hepatology · doi:10.1002/hep.29708 · Cited by 15 · see citing works

Natural killer T cells: Novel players in biliary disease?

Sebode, M., & Schramm, C. (2015) · Hepatology · doi:10.1002/hep.27862 · Cited by 4 · see citing works

Intrahepatic bile duct loss in immune-mediated ductopenic biliary diseases with an emphasis on biliary epithelial apoptosis.

Harada, K., & Nakanuma, Y. (2003) · PubMed · Cited by 4 · see citing works

The on-off action of Forkhead protein O3a in endotoxin tolerance of Kupffer cells depends on the PI3K/AKT pathway

Mu, D., Miao, C., Cheng, Y., Li, P., Gong, J., & Zhang, W. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106342 · Cited by 4 · see citing works

Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis

Sarcognato, S., Sacchi, D., Grillo, F., Cazzagon, N., Fabris, L., Cadamuro, M., Cataldo, I., Covelli, C., Mangia, A., & Guido, M. (2021) · Pathologica · doi:10.32074/1591-951x-245 · Cited by 118 · see citing works

Cholestasis: exploring the triangular relationship of gut microbiota-bile acid-cholestasis and the potential probiotic strategies

Yu, L., Liu, Y., Wang, S., Zhang, Q., Zhao, J., Zhang, H., Narbad, A., Tian, F., Zhai, Q., & Chen, W. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2181930 · Cited by 68 · see citing works

Intrahepatic cholangiocarcinoma: Morpho-molecular pathology, tumor reactive microenvironment, and malignant progression

Sirica, A. E., Strazzabosco, M., & Cadamuro, M. (2020) · Advances in cancer research · doi:10.1016/bs.acr.2020.10.005 · Cited by 59 · see citing works

The m6A writers regulated by the IL-6/STAT3 inflammatory pathway facilitate cancer cell stemness in cholangiocarcinoma

Ye, H., Chen, T., Zeng, Z., He, B., Yang, Q., Pan, Q., Chen, Y., & Wang, W. (2021) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2020.0661 · Cited by 36 · see citing works

Polycomb Directed Cell Fate Decisions in Development and Cancer

German, B., & Ellis, L. (2022) · Epigenomes · doi:10.3390/epigenomes6030028 · Cited by 36 · see citing works

Cancer Metabolism: The Role of Immune Cells Epigenetic Alteration in Tumorigenesis, Progression, and Metastasis of Glioma

Kanwore, K., Kanwore, K., Adzika, G. K., Abiola, A. A., Guo, X., Kambey, P. A., Xia, Y., & Gao, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.831636 · Cited by 25 · see citing works

The immunological landscape of primary biliary cholangitis: Mechanisms and therapeutic prospects

Ronca, V., Davies, S. P., Oo, Y. H., & Lleo, A. (2025) · Hepatology · doi:10.1097/hep.0000000000001225 · Cited by 22 · see citing works

Molecular Mechanisms of Clonorchis sinensis-Host Interactions and Implications for Vaccine Development

Koda, S., Zhu, X., Zheng, K., & Yan, C. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.781768 · Cited by 19 · see citing works

A regulatory variant at 19p13.3 is associated with primary biliary cholangitis risk and ARID3A expression

Li, Y., Li, Z., Chen, R., Lian, M., Wang, H., Wei, Y., You, Z., Zhang, J., Li, B., Li, Y., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37213-5 · Cited by 18 · see citing works

Macrophages in cholangiopathies

Bruneau, A., Guillot, A., & Tacke, F. (2021) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000814 · Cited by 18 · see citing works

Identification of atypical mitogen-activated protein kinase MAPK4 as a novel regulator in acute lung injury

Mao, L., Zhou, Y., Chen, L., Hu, L. T., Liu, S., Zheng, W., Zhao, J., Guo, M., Chen, C., He, Z., et al. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-00484-2 · Cited by 16 · see citing works

TLR3 activation by Clonorchis sinensis infection alleviates the fluke-induced liver fibrosis

Wang, Y., Gong, P., Zhang, X., Wang, X., Zhang, X., Zhang, N., Yu, Y., Ma, Y., Zhang, H., Zhang, X., et al. (2023) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0011325 · Cited by 14 · see citing works

Combining PD-1 Inhibitor with VEGF/VEGFR2 Inhibitor in Chemotherapy: Report of a Patient with End-Stage Cholangiocarcinoma and Review of Literature

Ma, Z., Li, H., & Liu, L. (2021) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/1574892815999201231215311 · Cited by 7 · see citing works

A Review on Biomarkers for the Evaluation of Autoimmune Cholestatic Liver Diseases and Their Overlap Syndromes

Nguyen, H. H., Fritzler, M. J., & Swain, M. G. (2022) · Frontiers in Molecular Medicine · doi:10.3389/fmmed.2022.914505 · Cited by 7 · see citing works

Immunotherapy-induced cholestasis in cancer: insights from the two real-world pharmacovigilance databases of FAERS and VigiBase

Yan, X., Li, Z., Jiang, A., Chen, J., Huang, X., Hajdú, A., Wong, H. Z. H., Cheng, Q., Zhang, J., Lin, A., et al. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000002607 · Cited by 6 · see citing works

Current and Emerging Molecular Markers of Liver Diseases: A Pathogenic Perspective

Liang, Y., Guo, G. L., & Zhang, L. (2022) · Gene Expression · doi:10.14218/gejlr.2022.00010 · Cited by 5 · see citing works

Dissecting the causal role of immunophenotypes in primary sclerosing cholangitis risk: A Mendelian randomization study

Zhou, J., Wang, H., Xu, Y., & Liu, Z. (2024) · Medicine · doi:10.1097/md.0000000000038626 · Cited by 2 · see citing works

Etiology, Epidemiology, and Therapeutic Approaches for Primary Sclerosing Cholangitis in the Context of Concurrent Non-specific Inflammatory Bowel Diseases

OLSZEWSKA, A., MATYJA, K., Berner, A., Stencel, K., Stelmaszak, K., MARCZYK, K., Polak, P., PĘKAŁA, M., POLASZEK, M., & Bogowska, M. (2024) · Journal of Education Health and Sport · doi:10.12775/jehs.2024.60.003 · Cited by 1 · see citing works

Trained immunity as a systemic bridge: the liver-gut-immune-oral axis in the comorbidity of chronic liver disease and periodontitis

Li, X., Lv, G., Yuan, D., Hu, J., Lou, W., Tu, Y., Zhou, J., & Qin, R. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1855561 · Cited by 1 · see citing works

Evolving paradigms in primary biliary cholangitis: from molecular mechanisms to personalized therapeutics with seladelpar, elafibranor, and beyond

Qasim, B., Kumari, H., Kashif, S. N., Abbas, S. M. I., Hani, O., Salma, O., Sauleh, A., Adnan, F., Ali, M., Raheem, A., et al. (2025) · Egyptian Liver Journal · doi:10.1186/s43066-025-00464-6

m7G Modification and Immune Infiltration Profiles in Primary Sclerosing Cholangitis

Wu, H., Lu, L., Yan, Y., Guo, Y., Chen, Y., Fang, J., & Li, Z. (2026) · Biomedical and Biotechnology Research Journal (BBRJ) · doi:10.4103/bbrj.bbrj_258_25

Nonsuppurative cholangitis induced in rodents by cholangiocyte immunization: An experimental model for immune cholangiopathies

Ueno, Y. (1993) · Hepatology · doi:10.1016/0270-9139(93)92207-g · Cited by 4 · see citing works

Immune-mediated cholangiopathies in children: the need to better understand the pathophysiology for finding the future possible treatment targets

Grama, A., Mititelu, A., Sîrbe, C., Bența, G., & Pop, T. L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1206025 · Cited by 12 · see citing works

867 Chemokines protect against paracetamol hepatotoxicity in model systems

Marek, C. J., Frew, J. W., Simpson, K. J., & Wright, M. C. (2003) · Hepatology · doi:10.1016/s0270-9139(03)80909-6

Immunopathogenesis: Insights for current and future therapies

Vierling, J. M. (2014) · Clinical Liver Disease · doi:10.1002/cld.309 · Cited by 1 · see citing works

28 Taurocholate feeding prevents the functional damage of intrahepatic bile ducts induced by adrenergic denervation in a PI3K dependent manner

Marzioni, M., Glaser, S. S., Francis, H., Taffetani, S., Marucci, L., Benedetti, A., Alvaro, D., Phinizy, J. L., Baumann, B., & Venter, J. (2003) · Hepatology · doi:10.1016/s0270-9139(03)80071-x · Cited by 2 · see citing works